Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Dec 11, 2020 6:44pm

45 Views

Post# 32091398

todays trades

House Positions for C:VXL from 20201211 to 20201211

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
19 Desjardins	21,000	2,100	0.10	0			21,000	-2,100
85 Scotia	59,750	5,957	0.10	39,500	3,752	0.095	20,250	-2,205
33 Canaccord	45,555	4,555	0.10	28,925	2,765	0.096	16,630	-1,790
1 Anonymous	147,100	13,990	0.095	131,000	13,100	0.10	16,100	-890
14 ITG	9,000	900	0.10	0			9,000	-900
79 CIBC	14,500	1,450	0.10	10,000	950	0.095	4,500	-500
9 BMO Nesbitt	1,600	152	0.095	1,500	142	0.095	100	-10
68 Leede	500	50	0.10	1,040	104	0.10	-540	54
124 Questrade	0			1,000	95	0.095	-1,000	95
7 TD Sec	109,335	10,693	0.098	130,555	12,452	0.095	-21,220	1,759
2 RBC	59,880	5,937	0.099	124,700	12,425	0.10	-64,820	6,488
TOTAL	468,220	45,784	0.098	468,220	45,785	0.098	0	1